Literature DB >> 21231797

The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties.

L G Gøransson1, K Haldorsen, J G Brun, E Harboe, M V Jonsson, K Skarstein, K Time, R Omdal.   

Abstract

OBJECTIVE: Primary Sjögren's syndrome (PSS) is a chronic autoimmune inflammatory disease characterized by exocrine gland inflammation producing clinical symptoms such as dryness of the mouth and eyes. The reported prevalence of PSS is variable, probably because of different classification criteria used and selection bias. The aim of this study was to determine the prevalence of PSS in a well-defined Norwegian Caucasian population using the revised American-European Consensus Group (AECG) criteria.
METHODS: Three hospitals and three private rheumatology practices provide all of the rheumatology services to the local population in Hordaland and Rogaland counties, which included 852 342 Caucasian inhabitants as of 1 January 2009. Patients on file fulfilling the new revised AECG criteria for PSS were included, and patients with incomplete data were invited to a screening visit.
RESULTS: A total of 424 PSS patients were identified. Their mean age was 61.6 ± 13.2 years; 28 (7%) were men and 396 (93%) were women. The point estimate for the proportion of PSS was 0.050% [95% confidence interval (CI) 0.048-0.052].
CONCLUSION: The prevalence of PSS in this Norwegian population of Caucasians is lower than previously reported when less stringent criteria for identifying PSS were used, but is in line with more recent studies using the same criteria and methods as in this study.

Entities:  

Mesh:

Year:  2011        PMID: 21231797     DOI: 10.3109/03009742.2010.536164

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  26 in total

1.  A possible genetic association with chronic fatigue in primary Sjögren's syndrome: a candidate gene study.

Authors:  Katrine Brække Norheim; Stephanie Le Hellard; Gunnel Nordmark; Erna Harboe; Lasse Gøransson; Johan G Brun; Marie Wahren-Herlenius; Roland Jonsson; Roald Omdal
Journal:  Rheumatol Int       Date:  2013-09-03       Impact factor: 2.631

2.  Changes in the Submandibular Salivary Gland Epithelial Cell Subpopulations During Progression of Sjögren's Syndrome-Like Disease in the NOD/ShiLtJ Mouse Model.

Authors:  Elise M Gervais; Kara A Desantis; Nicholas Pagendarm; Deirdre A Nelson; Tone Enger; Kathrine Skarstein; Janicke Liaaen Jensen; Melinda Larsen
Journal:  Anat Rec (Hoboken)       Date:  2015-07-16       Impact factor: 2.064

3.  Connective tissue diseases: Sjögren syndrome genetics vary according to ancestry.

Authors:  Tove Ragna Reksten; Roland Jonsson
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

4.  American Indians Have a Higher Risk of Sjögren's Syndrome and More Disease Activity Than European Americans and African Americans.

Authors:  R Hal Scofield; Rohan Sharma; Nathan Pezant; Jennifer A Kelly; Lida Radfar; David M Lewis; C Erick Kaufman; Sarah Cioli; Judy Harris; Kiely Grundahl; Nelson L Rhodus; Daniel J Wallace; Michael H Weisman; Swamy Venuturupalli; Michael T Brennan; Kristi A Koelsch; Christopher J Lessard; Courtney G Montgomery; Kathy L Sivils; Astrid Rasmussen
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-07-05       Impact factor: 4.794

5.  Prevalence of Primary Sjögren's Syndrome in a US Population-Based Cohort.

Authors:  Gabriel Maciel; Cynthia S Crowson; Eric L Matteson; Divi Cornec
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-08-31       Impact factor: 4.794

Review 6.  Studying Sjögren's syndrome in mice: What is the best available model?

Authors:  Ghada Abughanam; Ola M Maria; Simon D Tran
Journal:  J Oral Biol Craniofac Res       Date:  2020-12-08

Review 7.  Sjögren's syndrome in older patients: aetiology, diagnosis and management.

Authors:  Rada V Moerman; Hendrika Bootsma; Frans G M Kroese; Arjan Vissink
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

8.  Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort.

Authors:  Astrid Rasmussen; John A Ice; He Li; Kiely Grundahl; Jennifer A Kelly; Lida Radfar; Donald U Stone; Kimberly S Hefner; Juan-Manuel Anaya; Michael Rohrer; Rajaram Gopalakrishnan; Glen D Houston; David M Lewis; James Chodosh; John B Harley; Pamela Hughes; Jacen S Maier-Moore; Courtney G Montgomery; Nelson L Rhodus; A Darise Farris; Barbara M Segal; Roland Jonsson; Christopher J Lessard; R Hal Scofield; Kathy L Moser Sivils
Journal:  Ann Rheum Dis       Date:  2013-08-22       Impact factor: 19.103

9.  Interleukin-1 inhibition and fatigue in primary Sjögren's syndrome--a double blind, randomised clinical trial.

Authors:  Katrine Brække Norheim; Erna Harboe; Lasse G Gøransson; Roald Omdal
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

10.  A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA.

Authors:  Raphael Carapito; Jacques-Eric Gottenberg; Irina Kotova; Meiggie Untrau; Sandra Michel; Lydie Naegely; Ismail Aouadi; Marius Kwemou; Nicodème Paul; Angélique Pichot; James Locke; Simon J Bowman; Bridget Griffiths; Kathy L Sivils; Jean Sibilia; Hidetoshi Inoko; Corinne Micelli-Richard; Gaétane Nocturne; Masao Ota; Wan-Fai Ng; Xavier Mariette; Seiamak Bahram
Journal:  Hum Mol Genet       Date:  2017-07-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.